Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death.

Abstract

The induction of apoptosis is frequently accompanied by the exposure of phosphatidylserine (PS) on the cell surface, which has been detected using radionuclide and fluorescently labeled derivatives of the PS-binding protein, Annexin V. The fluorescently labeled protein has been used extensively in vitro as a diagnostic reagent for detecting cell death, and radionuclide-labeled derivatives have undergone clinical trials for detecting tumor cell death in vivo following treatment. We show here that the C2A domain of Synaptotagmin-I, which had been fluorescently labeled at a single cysteine residue introduced by site-directed mutagenesis, detected the same levels of cell death as a similarly labeled Annexin-V derivative, in drug-treated murine lymphoma and human breast cancer cell lines in vitro. However, the C2A derivative showed significantly less binding to viable cells and, as a consequence, up to 4-fold more specific binding to apoptotic and necrotic cells when compared with Annexin-V. C2A offers a potential route for the development of a new generation of more specific imaging probes for the detection of tumor cell death in the clinic.

DOI: 10.1021/bc9004415
0204020102011201220132014201520162017
Citations per Year

99 Citations

Semantic Scholar estimates that this publication has 99 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Alam2010ComparisonOT, title={Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death.}, author={Israt S. Alam and Andr{\'e} A Neves and Timothy Howard Witney and Joan Boren and Kevin M Brindle}, journal={Bioconjugate chemistry}, year={2010}, volume={21 5}, pages={884-91} }